IP Library Granted Patent US 9,463,066
Granted Patent B2
US 9,463,066 · App. 14/878,898 · Granted Oct 11, 2016

Methods for renal neuromodulation

Inventors: Mark Deem (Mountain View, CA); Denise Zarins (Saratoga, CA); Douglas Sutton (Pacifica, CA); Hanson Gifford, III (Woodside, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY); Benjamin J. Clark (Redwood City, CA)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/1492A61B2018/00267A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00702A61B2018/00779A61B2018/00791A61B2018/00875A61B2018/00982A61B2018/1435A61N1/0551A61N1/36007A61N1/36017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,463,066
App. No.
14/878,898
Granted
Oct 11, 2016
Kind
B2
Abstract

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.

Claims (30)

1. A method for renal neuromodulation, the method comprising:

positioning a spiral element of a catheter at an extra-arterial location within a human patient and adjacent to neural fibers innervating a kidney of the patient;

transforming the spiral element from a low-profile delivery configuration to an expanded treatment configuration,

wherein, in the treatment configuration, the spiral element is sized and shaped to place a plurality of individual, discrete electrodes arranged thereabout in apposition with target tissue at or near the neural fibers; and

ablating the neural fibers innervating the kidney via radio frequency (RF) energy from the electrodes, wherein ablating the neural fibers innervating the kidney results in a therapeutically beneficial reduction in blood pressure in the patient.

2. The method of claim 1 wherein positioning a spiral element of a catheter at an extra-arterial location comprises positioning the spiral element at a renal hilum of the patient.

3. The method of claim 1 wherein positioning a spiral element of a catheter at an extra-arterial location comprises positioning the spiral element adjacent a renal hilum of the patient.

4. The method of claim 1 wherein positioning a spiral element of a catheter at an extra-arterial location comprises delivering the catheter to the extra-arterial location over a guidewire.

5. The method of claim 1 wherein ablating the neural fibers innervating the kidney comprises ablating at least one of an efferent nerve and an afferent nerve via RF energy from the electrodes.

6. The method of claim 1 wherein ablating the neural fibers innervating the kidney comprises at least partially denervating the kidney.

7. The method of claim 1 wherein ablating the neural fibers innervating the kidney via RF energy comprises delivering the RF energy in a monopolar fashion between one or more of the electrodes and an external ground pad attached to the patient.

8. The method of claim 1 wherein ablating the neural fibers innervating the kidney via RF energy comprises delivering the RF energy in a bipolar fashion.

9. The method of claim 1 , further comprising removing the catheter from the patient after ablating the neural fibers.

10. A method for treatment of a hypertensive human patient, the method comprising:

extravascularly positioning a pre-shaped distal segment of a treatment device proximate renal nerves of the patient, wherein the pre-shaped distal segment comprises a plurality of energy delivery elements; and

delivering an energy field via the energy delivery elements to disrupt neural traffic along the renal nerves wherein disrupting the neural traffic along the renal nerves reduces neural signaling to and from a kidney of the patient,

wherein delivering the energy field results in a therapeutically beneficial reduction in blood pressure of the patient.

11. The method of claim 10 wherein extravascularly positioning a pre-shaped distal segment of a treatment device proximate renal nerves comprises positioning the pre-shaped distal segment at or near a renal hilum of the patient.

12. The method of claim 10 wherein extravascularly positioning a pre-shaped distal segment of a treatment device proximate renal nerves comprises inserting the pre-shaped distal segment in proximity to the renal nerves and along a renal blood vessel of the patient.

13. The method of claim 10 wherein extravascularly positioning a pre-shaped distal segment of a treatment device proximate renal nerves comprises delivering the treatment device over a guidewire.

14. The method of claim 10 wherein extravascularly positioning a pre-shaped distal segment of a treatment device proximate renal nerves comprises delivering the pre-shaped distal segment within an introducer, and wherein the method further comprises at least partially withdrawing the introducer before delivering the energy field.

15. The method of claim 10 wherein the pre-shaped distal segment comprises a helical shape, and wherein the pre-shaped distal segment is transformable between (a) a low profile delivery configuration and (b) an expanded configuration that tends to assume the helical shape and positions the energy delivery elements in contact with tissue at or near the renal nerves before delivering the energy field.

16. The method of claim 10 wherein delivering an energy field via the energy delivery elements comprises delivering radio frequency (RF) energy to the renal nerves via the energy delivery elements.

17. The method of claim 16 wherein delivering RF energy to the renal nerves via the energy delivery elements comprises delivering RF energy in a monopolar fashion between one or more of the energy delivery elements and an external ground pad attached to an exterior of the patient.

18. The method of claim 10 , further comprising monitoring a parameter of the device and/or tissue within the patient before and during delivery of the energy field.

19. The method of claim 18 wherein monitoring a parameter comprises monitoring power, temperature, and/or impedance.

20. The method of claim 18 , further comprising altering delivery of the energy field in response to the monitored parameter.

21. The method of claim 10 delivering an energy field via the energy delivery elements comprises ablating renal nerves of the patient.

22. The method of claim 10 wherein delivering an energy field via the energy delivery elements comprises partially ablating renal nerves of the patient.

23. The method of claim 10 , further comprising removing the treatment device from the patient after delivering the energy field to conclude the procedure.

Continuity (13)
Continuation 14279023 · May 15, 2014
Continuation 13942223 · Jul 15, 2013
Continuation 13361542 · Jan 30, 2012
Division 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Related Publication 20160100883A1 · Apr 14, 2016